Texas-based G-Con Manufacturing, LLC and GE Healthcare, a
unit of General Electric Company, announced today their intention to
collaborate on the development of an industry-leading modular portable
bio-process manufacturing solution for vaccines and therapeutics.
This collaboration combines GE Healthcare’s global presence
and expertise in biopharmaceutical manufacturing technology with G-Con’s
modular portable flexible clean-room technology. The collaboration will offer
comprehensive GMP manufacturing solutions that are less expensive and quicker
to build and maintain and easier to operate than any currently existing
solution on the market.
Together, the companies have the capability to design, build
and deliver turnkey advanced bio-therapeutic manufacturing facilities
throughout the world, and will be able to meet the growing market for rapid
access to biopharmaceutical manufacturing capabilities, whether in developing
markets, or for increased speed in situations such as pandemic response.
“GE Healthcare is a global life sciences leader, and we are
excited by the market-changing next generation therapeutic manufacturing
innovations this collaboration will be able to produce,” said Dr. Barry Holtz,
President of G-Con Manufacturing, LLC.
“This collaboration is part of GE Healthcare’s mission to
increase speed and access, and reduce cost for developers and manufacturers of
bio-therapeutics and vaccines around the world,” said Nigel Darby, Vice
President, Biotechnologies, GE Healthcare. “This collaboration means we move
further towards our vision of modular and possibly mobile flexible
bio-pharmaceutical manufacturing facilities – the vaccine factory in a box.”
